We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Bone morphogenetic protein-10 suppresses the growth and aggressiveness of prostate cancer cells through a Smad independent pathway.
Journal of Urology 2009 June
PURPOSE: BMPs have been implicated in the development of bone metastasis in prostate cancer. We investigated the role of BMP-10 in prostate cancer and prostate cancer cells.
MATERIALS AND METHODS: BMP-10 expression was examined in human prostate tissue and prostate cancer cell lines. BMP-10 was experimentally over expressed in human prostate cancer cells. The influence of BMP-10 on the biological behavior of prostate cancer cells was then investigated in in vitro studies.
RESULTS: BMP-10 expression was decreased or absent in prostate tumors, particularly in higher grade foci. Forced BMP-10 over expression in prostate cancer cells decreased in vitro growth, cell matrix adhesion, invasion and migration. Furthermore, BMP-10 induced apoptosis in prostate cancer cells through a Smad independent pathway, in which the 2 downstream candidates of BMP receptors XIAP (ILP) and ERK1/2 were activated. Interestingly the failure of BMP-10 to activate BMP receptor-II and the Smads in WT cells was due to the expression of BMP receptor-IB, which acted as a negative regulator of BMP receptor-II mediated Smad dependent signaling.
CONCLUSIONS: BMP-10 inhibits the growth of prostate cancer cells due largely to induced apoptosis via Smad independent signaling in which XIAP and ERK1/2 are involved. BMP-10 can also prevent prostate cancer cell migration and invasiveness. This suggests that BMP-10 may function as a tumor suppressor and apoptosis regulator for prostate cancer.
MATERIALS AND METHODS: BMP-10 expression was examined in human prostate tissue and prostate cancer cell lines. BMP-10 was experimentally over expressed in human prostate cancer cells. The influence of BMP-10 on the biological behavior of prostate cancer cells was then investigated in in vitro studies.
RESULTS: BMP-10 expression was decreased or absent in prostate tumors, particularly in higher grade foci. Forced BMP-10 over expression in prostate cancer cells decreased in vitro growth, cell matrix adhesion, invasion and migration. Furthermore, BMP-10 induced apoptosis in prostate cancer cells through a Smad independent pathway, in which the 2 downstream candidates of BMP receptors XIAP (ILP) and ERK1/2 were activated. Interestingly the failure of BMP-10 to activate BMP receptor-II and the Smads in WT cells was due to the expression of BMP receptor-IB, which acted as a negative regulator of BMP receptor-II mediated Smad dependent signaling.
CONCLUSIONS: BMP-10 inhibits the growth of prostate cancer cells due largely to induced apoptosis via Smad independent signaling in which XIAP and ERK1/2 are involved. BMP-10 can also prevent prostate cancer cell migration and invasiveness. This suggests that BMP-10 may function as a tumor suppressor and apoptosis regulator for prostate cancer.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app